Immatics Reports Interim Clinical Data from ACTengine®

Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial

Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , University Hospital , Texas , United States , Philadelphia , Pennsylvania , Houston , Cedrik Britten , Sabrina Schecher , Instagramand Linkedin , Immatic Actengine , Charlotte Spitz , Martin Wermke , Society For Melanoma Research , Exchange Commission , Trophic Communications , Twitter , International Congress , University Hospital Dresden , Melanoma Research , Cell Therapy , Coordinating Investigator , Chief Medical Officer , Regenerative Medicine Advanced Therapy , Median Follow Up , All Immatic , Stem Cell Therapeutics Research Laboratory , Adoptive Cell Therapies , Looking Statements , Investor Relations , Ihre Watchlist ,